secwatch.observer — SEC 8-K summary
======================================

Issuer:     CME GROUP INC. (CME)
CIK:        0001156375
Form:       8-K
Filed at:   2022-12-09T23:59:59+00:00
Accession:  0001193125-22-301477
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CME Group amends bylaws for Universal Proxy Rules compliance, removes Class B Nominating Committee references
--------------------------------------------------------------------------------

- Board approved and adopted Amended Bylaws effective Dec 7, 2022, addressing Universal Proxy Rule 14a-19.
- Requires evidence of shareholder compliance with Universal Proxy solicitation requirements.
- Company provided a remedy if a shareholder fails to satisfy Universal Proxy Rules.
- Removed references to Class B Nominating Committees, which concluded as of 2020 Annual Meeting.
- Also includes non-substantive and clarifying changes to Bylaws.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156375/000119312522301477/0001193125-22-301477-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156375/000119312522301477/d412380d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-301477

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer